Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trialAndrea Necchi, Roberto Salvioni, Salvatore Lo Vullo et al.|Annals of Oncology|2017Cited by 46
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glandsStefano Cavalieri, Laura D. Locati, Cristiana Bergamini et al.|European Journal of Cancer|2020Cited by 40
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRIGiorgio Brembilla, Francesco De Cobelli, Giuseppe Basile et al.|Radiology|2024Cited by 31
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA TrialLaura Marandino, Andrea Necchi, Daniele Raggi et al.|Clinical Genitourinary Cancer|2021Cited by 16